MTNB · Matinas BioPharma Holdings, Inc. · Executive Compensation
$1.70
-0.01 (-0.55%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company does not believe that the cash and cash equivalents on hand are sufficient to fund planned operations for a period of at least twelve months from the filing date of these financial statements. As a result, substantial doubt exists about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$1.67M
Shares
979,520
Volume · Oct 23
11.29K
Avg daily vol (20 sessions)
144.48K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Jerome D. Jabbour | Chief Executive Officer | $598,000 |
| Jerome Jabbour | CEO | $598,000 |
| James Ferguson | Former Chief Medical Officer | $589,680 |
| Keith Kucinski | Chief Financial Officer | $584,160 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Jerome D. Jabbour | Chief Executive Officer | $1,599,551 |
| Jerome Jabbour | CEO | $1,599,551 |
| James Ferguson | Former Chief Medical Officer | $880,603 |
| Keith Kucinski | Chief Financial Officer | $808,347 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Jerome Jabbour | CEO | $1,674,207 |
| Jerome D. Jabbour | Chief Executive Officer | $1,674,207 |
| James Ferguson | Chief Medical Officer | $869,099 |
| Theresa Matkovits | Chief Development Officer | $850,179 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Jerome Jabbour | CEO | $3,693,314 |
| Jerome D. Jabbour | Chief Executive Officer | $3,693,314 |
| James Ferguson | Chief Medical Officer | $1,621,937 |
| Theresa Matkovits | Chief Development Officer | $1,338,161 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Jerome D. Jabbour | Chief Executive Officer | $2,930,085 |
| Jerome Jabbour | CEO | $2,930,085 |
| James Ferguson | Chief Medical Officer | $1,650,043 |
| Theresa Matkovits | Chief Development Officer | $1,253,030 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Jerome Jabbour | CEO | $1,325,176 |
| Jerome D. Jabbour | Chief Executive Officer | $1,325,176 |
| James Ferguson | Chief Medical Officer | $752,315 |
| Theresa Matkovits | Chief Development Officer | $698,138 |
| Keith Kucinski | Chief Financial Officer | $626,595 |
| Roelof Rongen | Former Chief Executive Officer | $183,333 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Jerome D. Jabbour | Chief Executive Officer | $1,254,727 |
| Jerome Jabbour | CEO | $1,254,727 |
| Roelof Rongen | Former Chief Executive Officer | $400,000 |
| Theresa Matkovits | Chief Development Officer | $306,300 |
| Keith Kucinski | Chief Financial Officer | — |
| James Ferguson | Chief Medical Officer | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Robin L. Smith | Board | Resigned | 2026-07-13 |
| Jerome D. Jabbour | interim Chief Financial Officer | Appointed | 2026-01-23 |
| Keith Kucinski | Chief Financial Officer | Resigned | 2026-01-23 |
| Keith Kucinski | Chief Financial Officer | Resigned | 2025-11-21 |
| Robin L. Smith | Director | Appointed | 2025-06-23 |
| Edward Neugeboren | Director | Appointed | 2025-06-23 |
| Evelyn D'An | Director | Appointed | 2025-06-23 |
| Keith Murphy | Director | Appointed | 2025-06-23 |
| Jerome D. Jabbour | Director | Appointed | 2025-06-23 |
| Eric Ende | member of the Board | Resigned | 2025-03-14 |
| Eric Ende | Chairman of the Board | Resigned | 2025-03-14 |
| Edward Neugeboren | directors of the Company | Appointed | 2025-03-11 |
| Keith Murphy | directors of the Company | Appointed | 2025-03-11 |
| Matthew Wikler | Board of Directors | Resigned | 2025-03-11 |
| Natasha Giordano | Board of Directors | Resigned | 2025-03-11 |
| Robin L. Smith | Board of Directors | Appointed | 2025-02-13 |
| Dr. Robin L. Smith | First Preferred Nominee | Appointed | 2025-02-13 |
| Robin Smith | director | Appointed | 2025-02-13 |
| Herbert Conrad | Board of Directors | Retired | 2025-02-11 |
| Evelyn D'An | director | Appointed | 2025-02-07 |
| James S. Scibetta | Board of Directors | Resigned | 2025-01-24 |
| Kathryn Penkus Corzo | Board | Resigned | 2024-11-27 |
| James Ferguson, M.D. | Chief Medical Officer | Terminated | 2024-10-31 |
| Theresa Matkovits, Ph.D. | Chief Development Officer | Resigned | 2024-10-24 |
Leadership
- Jerome D. Jabbour CEO, CFO, Board Member
- Eric Ende Chairman
- Hui Liu CTO
- Hui Liu, Ph.D., M.B.A. CTO
- Dr. Robin L. Smith Board Member
- Edward Neugeboren Board Member
- Evelyn D'An Board Member
- Evelyn D’An Board Member
- Jerome Jabbour Board Member
- Keith Murphy Board Member
- Robin L. Smith Board Member
- Robin Smith Board Member